Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Clinical trial NCT01188733 · COMPLETED

Trial details

NCT number: NCT01188733
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cirrhosis Portal Hypertension Esophageal Varices

Start date: 1998-06-01
Primary completion: 2000-07-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.